Status:
COMPLETED
Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease.
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The use of cryoprobes improves the diagnostic yield in transbronchial biopsies compared to forceps biopsies to diagnose an interstitial lung disease
Detailed Description
Endoscopic biopsy currently plays only a minor role for the diagnosis of interstitial lung disease. However, in some cases obtaining lung tissue is necessary to establish a final diagnosis. The curren...
Eligibility Criteria
Inclusion
- Clinical indications for biopsy of interstitial lung disease
- Age over 18 years
- Signed consent
Exclusion
- Risk of bleeding / ongoing anticoagulation
- Oxygen saturation \<90% - despite delivery of 2l oxygen / min
- Underlying cardiac disease (unstable angina, myocardial infarction during the last month, congestive heart failure)
- Pulmonary hypertension, PAP sys\> 50mmHg
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2014
Estimated Enrollment :
382 Patients enrolled
Trial Details
Trial ID
NCT01894113
Start Date
January 1 2012
End Date
May 1 2014
Last Update
May 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Tuebingen
Tübingen, Germany